Cite
HARVARD Citation
Mease, P. et al. (n.d.). AB0785 Consistent safety profile with up to 4 years of apremilast treatment: analysis of data from 1493 patients with psoriatic arthritis in 3 large, phase iii, long-term studies. Annals of the rheumatic diseases. pp. 1331-1332. [Online].